Flourish Research Continues Expansion with Acquisition of Center for Advanced Research & Education

Acquisition Expands Flourish Research's Geographic Footprint in Southeast Region and Bolsters Relationships with Blue-Chip Pharmaceutical Customers

, /PRNewswire/ -- Flourish Research ("Flourish"), a leading multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, today announced the acquisition of the Center for Advanced Research & Education ("CARE"), a leading multi-therapeutic research facility dedicated to advancing innovation in healthcare through conducting phase I-IV clinical trials.

Founded in 1998 by Drs. Chris and Julie Recknor and headquartered in Gainesville, GA, CARE has conducted over 150 clinical trials across multiple therapeutic areas and is recognized for its commitment to excellence and science-forward, patient-centric research.

Reinhold Schulz, Chief Executive Officer of Flourish, commented, "Flourish has been highly impressed with CARE's exceptional history of patient engagement across a diverse set of therapeutic areas. We look forward to collaborating with CARE's physician-led leadership team to accelerate our expansion within the oncology market and further cultivate relationships with their prominent pharmaceutical customers. The addition of CARE's state-of-the-art facility also expands Flourish's presence into the Southeast region."

Dr. Chris Recknor, Principal Investigator and Co-Founder of CARE, added, "This marks an exciting milestone for CARE and our team as we continue our journey of advancing clinical research to bring life-enhancing therapies to market. By joining forces with Flourish, we unlock opportunities to deliver best-in-class patient care at even greater scale."

Quadriga Partners, LLC acted as financial advisor to CARE. Ropes & Gray acted as legal counsel to Flourish.

About Flourish Research

Headquartered in Apex, NC, Flourish's network of 27 sites and over 152 investigators conducts studies spanning all phases of clinical trial research. The Company is known for deep medical expertise in several therapeutic areas and a reliable, predictable, and timely patient recruitment experience. With best-in-class technology, quality, and operations systems, Flourish is well-positioned to best serve patients and its biopharma sponsor and CRO clients to advance clinical research in an efficient manner. For additional information on Flourish, please visit our website at https://flourishresearch.com.

Media Contact

FGS Global
Miranda Dunne
[email protected]

SOURCE Flourish Research